Natera, Inc. is a clinical genetic testing company based in Austin, Texas, that specializes in non-invasive cell-free DNA (cfDNA) testing technology focused on oncology, women's health, and organ health. Founded in 2004 by Matthew Rabinowitz and Jonathan Sheena, the company offers tests such as Panorama for non-invasive prenatal testing, Signatera for molecular residual disease in cancer, and Prospera for transplant rejection assessment. It operates CAP-accredited and CLIA-certified laboratories in Austin, Texas, and San Carlos, California.